 |
|
A Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine in Korean Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder
Soochurl Cho, Soyoung Irene Lee, Hanik Yoo, Dong Ho Song, Dong-Hyun Ahn, Dong Won Shin, Sun Young Yum, Richard Walton, Luis Mendez
Psychiatry Investig. 2011;8(2):141-148. Published online 2011 Jan 19 DOI: https://doi.org/10.4306/pi.2011.8.2.141
|
|
Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology
Jessica L. Gayleard, Matthew P. Mychailyszyn
ADHD Attention Deficit and Hyperactivity Disorders.2017; 9(3): 149. CrossRef The Revised Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder (III) - Pharmacological Treatment -
Hyo-Won Kim, Eunjoo Kim, Ji-Hoon Kim, Jangho Park, Geon Ho Bahn, Yeon Jung Lee, Kyungun Jhung, Dongwon Shin
Journal of the Korean Academy of Child and Adolescent Psychiatry.2017; 28(2): 70. CrossRef The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research
Nicola C. Savill, Jan K. Buitelaar, Ernie Anand, Kathleen Ann Day, Tamás Treuer, Himanshu P. Upadhyaya, David Coghill
CNS Drugs.2015; 29(2): 131. CrossRef Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder
Michael R. Kohn, Tracey W. Tsang, Simon D. Clarke
Clinical Medicine Insights: Pediatrics.2012; 6: CMPed.S7868. CrossRef
|